» Articles » PMID: 23007601

A Dysphoric-like State During Early Withdrawal from Extended Access to Methamphetamine Self-administration in Rats

Overview
Specialty Pharmacology
Date 2012 Sep 26
PMID 23007601
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Negative emotional states during drug withdrawal may contribute to compulsive drug intake and seeking in humans. Studies suggest that extended access to methamphetamine induces compulsive drug intake in rats.

Objective: The present study tested the hypothesis that compulsive methamphetamine intake in rats with extended access is associated with negative emotional states during drug withdrawal.

Methods: Rats with short (1 h, ShA) and extended access (6 h, LgA) to methamphetamine self-administration (0.05 mg/kg/infusion) were tested for reward thresholds using intracranial self-stimulation (ICSS). Different groups of ShA and LgA rats were examined for depression-like and anxiety-like states in the novelty-suppressed feeding, open field, defensive burying, and forced swim tests.

Results: With extended access, ICSS thresholds gradually increased, which was correlated with the increase of drug intake. During drug withdrawal, the increased ICSS thresholds returned to levels observed before exposure to extended access to methamphetamine. Upon re-exposure to extended access to methamphetamine, ICSS thresholds showed a more rapid escalation than during the initial exposure. LgA rats showed a longer latency to approach chow in the center of a novel field and remained immobile longer in the forced swim test than ShA rats did during early withdrawal. In contrast, ShA rats actively buried an aversive shock probe whereas LgA rats remained immobile in the defensive burying test.

Conclusion: The data suggest that extended access to methamphetamine produces a more depressive-like state than anxiety-like state in rats during early withdrawal.

Citing Articles

Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice.

Denning C, Madory L, Herbert J, Cabrera R, Szumlinski K Int J Mol Sci. 2024; 25(3).

PMID: 38339206 PMC: 10856401. DOI: 10.3390/ijms25031928.


Interaction effects between smoking and internet gaming disorder on resting-state functional connectivity of the ventral tegmental area and hippocampus.

Qiu X, Han X, Wang Y, Ding W, Sun Y, Lei H Front Neurosci. 2023; 17:1270014.

PMID: 37965221 PMC: 10641398. DOI: 10.3389/fnins.2023.1270014.


Emotional Contagion and Social Support in Pigs with the Negative Stimulus.

Zhang Y, Yu J, Zhang Y, Zhang Y, Sun F, Yao Y Animals (Basel). 2023; 13(20).

PMID: 37893884 PMC: 10603741. DOI: 10.3390/ani13203160.


The Association of High-Frequency Nut Intake With a Low Risk of Psychological Problems in Female Methamphetamine Users.

Song Z, Dong F, Liu Y, Liu G, Li B, Pang X Front Psychiatry. 2022; 13:878859.

PMID: 36046161 PMC: 9421136. DOI: 10.3389/fpsyt.2022.878859.


Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Nguyen J, Grant Y, Taffe M Br J Pharmacol. 2021; 178(18):3797-3812.

PMID: 33948939 PMC: 8387405. DOI: 10.1111/bph.15520.


References
1.
Markou A, Koob G . Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 1991; 4(1):17-26. View

2.
Britton D, Britton K . A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav. 1981; 15(4):577-82. DOI: 10.1016/0091-3057(81)90212-4. View

3.
Ahmed S, Kenny P, Koob G, Markou A . Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci. 2002; 5(7):625-6. DOI: 10.1038/nn872. View

4.
Ahmed S, Koob G . Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998; 282(5387):298-300. DOI: 10.1126/science.282.5387.298. View

5.
Macey D, Koob G, Markou A . CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res. 2000; 866(1-2):82-91. DOI: 10.1016/s0006-8993(00)02229-0. View